Delivery Order SPE2DR25D2104-SPE2DR26F3NLM
Award Date 11/5/25
Potential Completion Date 11/6/25
Potential Value $7.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,717.04 to AmerisourceBergen Drug Corp for 24,000-unit capsules of Creon (pancreatic enzyme replacement therapy) on October 27, 2025, with completion targeted for October 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles, valued at $31,396.02. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $5,909.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of 36,000 unit capsules of Creon (pancrelipase) in 100-unit packages. The delivery order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, with completion scheduled for November 5, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $77,595.73 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules. This non-competitive delivery order, issued on November 3, 2025, represents a firm fixed price procurement with a completion date of November 4, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract is classified as a child order under a larger contract...
- The Defense Logistics Agency awarded a $6,997.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on November 3, 2025, with completion targeted for November 4, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,288.51 to AmerisourceBergen Drug Corp for 36,000-unit capsules of Creon (pancrelipase) in 100-unit quantities. The contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,101.10 to AmerisourceBergen Drug Corp on July 24, 2025, for 12,000 unit capsules of Creon (pancrelipase) in 100-count bottles. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, carrying an ultimate completion date of July 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply contract. This...
- The Defense Logistics Agency awarded a $9,903.51 delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,524.22 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles. The contract, executed on November 4, 2025, with completion targeted for November 5, 2025, employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Creon DR 24,000 unit capsules (100 count) with a ceiling value of $2,262.52 and an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...